Hypokinetic dysarthria (HD) is a motor speech disorder present in up to 90% of patients with Parkinson’s disease (PD). HD can manifest in the areas of respiration, phonation, articulation, and/or prosody, having a detrimental impact on patients' quality of life. Since the most common approach to PD treatment (i.e., based on L-DOPA) has a very individual effect on HD (likely dependent on the progression and subtype of PD), we have collaborated with neuroscientists, psychologists, and speech-language pathologists from the CEITEC - Central European Institute of Technology to explore new possibilities for improving speech in PD patients. For instance, within the framework of the project "Effects of non-invasive brain stimulation on hypokinetic dysarthria, micrographia, and brain plasticity in patients with Parkinson's disease" (https://lnkd.in/e-bATJfd), we have identified a beneficial effect of repetitive transcranial magnetic stimulation of the right superior temporal gyrus on articulation and other speech aspects: 1. https://lnkd.in/dhPSpEJc 2. https://lnkd.in/eMf_ukJF 3. https://lnkd.in/eG_yT4JU Subsequently, we became involved in a project (refer to https://lnkd.in/esGsYjhf) led by Luboš Brabenec, where we are currently supporting efforts to simplify the entire process, enabling patients to administer the stimulation themselves at home. In this case, we are utilizing the technology of transcranial direct-current stimulation in combination with the Lee Silverman Voice Treatment. Initial results will be published soon. Throughout this research, digital vocal biomarkers are extensively employed to facilitate neuroscientists in objectively monitoring the effects of new therapies and determining their optimal settings. If you are interested in applying digital vocal biomarkers in your own studies or clinical trials, we would be more than happy to assist you. Brno University of Technology #ParkinsonsDisease #dysarthria #treatment #rTMS #tDCS #DigitalBiomarkers #speech #voice #pathology
Brain Diseases Analysis Laboratory
Výzkumné služby
Královo Pole, South Moravia 215 sledující uživatelů
Developing interpretable and trustworthy digital biomarkers
O nás
The Brain Diseases Analysis Laboratory (BDALab) is an international multidisciplinary research group (based at the Brno University of Technology) focusing on the research and development of digital biomarkers. Using state-of-the-art techniques of biomedical signal processing, data science, and wearable technologies we provide experts with digital biomarkers facilitating diagnosis, assessment and monitoring of a large spectrum of disorders such as Parkinson’s disease, Alzheimer’s disease, Lewy body dementia, neurodevelopmental dysgraphia, etc. We offer a design and implementation of software that can objectively analyse different modalities such as speech, handwriting, and sleep. All solutions provided by BDALab are individualized depending on the customer’s requirements.
- Web
-
https://bdalab.utko.fekt.vut.cz/
Externí odkaz pro organizaci Brain Diseases Analysis Laboratory
- Obor
- Výzkumné služby
- Velikost společnosti
- 2 – 10 zaměstnanců
- Ústředí
- Královo Pole, South Moravia
- Typ
- Veřejná společnost
- Datum založení
- 2014
- Speciality
- digital biomarkers, research, development, digital endpoints, signal processing, machine learning, AI, wearables, time series, digital health, neuroscience, psychology, acoustic analysis, online handwriting, image processing a mHealth
Lokality
-
Primární
Technická 12
Královo Pole, South Moravia 612 00, CZ
Zaměstnanci společnosti Brain Diseases Analysis Laboratory
-
Jiri Mekyska
Digital Biomarkers | Digital Medicine | Director of the Brain Diseases Analysis Laboratory at BUT | Co-Founder and Chief Scientific Officer at Scicake
-
Matej Gradoš
MSc student @ Tampere University && Brno University of Technology
-
Zoltán Galáž 👨🍳
Scicake CTO & Co-founder | BDALab Leading Scientist | Digital Health | Data Science
-
Ján Mucha 👨💻
Scicake CEO & Co-founder | BDALab Leading Scientist | Digital Health | Machine Learning
Aktualizace
-
Uživatel Brain Diseases Analysis Laboratory to přesdílel
🍰 Meet Scicake at the Velvet Innovation Conference 🚀 The Velvet Innovation Conference is one of the year’s premier events for the local innovation ecosystem in Brno, our hometown. This year we are part of the Pitch Session where we will unveil an exciting new phase for Scicake! Want to be among the first to know? Stay tuned, big things are on the horizon! Ján Mucha 👨💻, Zoltán Galáž 👨🍳, Jan Svoboda, Kristína Galážová #Scicake #AI #VelvetInnovation #Conference #Innovation #Startup #BrnoRegion
-
Uživatel Brain Diseases Analysis Laboratory to přesdílel
Digital Biomarkers | Digital Medicine | Director of the Brain Diseases Analysis Laboratory at BUT | Co-Founder and Chief Scientific Officer at Scicake
Jan Rusz, a leading expert in digital speech biomarkers for Parkinson’s disease, along with his colleagues Paul Krack and Elina Tripoliti, has just published an outstanding review in this field. If you're interested in the current state, opportunities, knowledge gaps, and challenges, this review has it all in one place! #ParkinsonsDisease #DigitalBiomarkers #Hypokinetic #Dysarthria #Speech
-
Uživatel Brain Diseases Analysis Laboratory to přesdílel
Direct decoding of signals from the brain has long been science fiction, but now the research community, as well as technology companies (e.g. Neuralink funded by Elon Musk) are making significant progress. At the VGS-IT (https://lnkd.in/epxVRdbN) seminar on December 5 (14:00, E112), Dr. Julia Berezutskaya, researcher at the University Medical Center Utrecht in the Netherlands, a leading European laboratory dedicated to Brain-Computer Interfaces (BCI), will update us on what is and what is not possible. The lecture is open to the public and Julia has been instructed to be gentle to us IT/ML/AI guys about "brain-information" - everyone is cordially invited.
-
Uživatel Brain Diseases Analysis Laboratory to přesdílel
Can you objectively (& quickly) measure fatigue? 🤔 Marcelo D. & the team at ki:elements provide some evidence that using speech, yes you can... In this week's R&R I look at a cool paper that suggests we can use speech to measure fatigue in people with #multiplesclerosis using even less data than first thought. One to read if you’re interested in 🗣 Speech as an outcome measure 📉 Measuring the subjective ⏲ Streamlining assessment batteries If you’re interested in this check out Dr Michele Veldsman's article for Clinical Leader about the challenges of defining & measuring fatigue 📑 https://lnkd.in/eVP7fw-t No Next-Up this week as I'm taking a long weekend for an overdue trip back to England to see friends & family. As always link to the full paper available in the comments 👇
-
Uživatel Brain Diseases Analysis Laboratory to přesdílel
🔍 Thrilled to share insights from our recent study on the ethical dimensions of using voice as a health biomarker in AI! Conducted with the support of the Bridge2AI-Voice Consortium, this research highlights the diverse perspectives of stakeholders—including experts, clinicians, and patients—on the challenges and opportunities in developing trustworthy voice AI technologies. 📊 Key findings include: - Identification of ethical priorities for voice AI development - Initial definitions of ethically sourced data - Insights into the role of synthetic voice data By understanding these perspectives, we can work towards creating voice datasets that are free from bias, promoting inclusion, and addressing health disparities in marginalized communities. This study is a significant step forward in ensuring that voice AI technologies are both ethical and effective in health applications. For more details, check out the full study here: https://lnkd.in/eQ8d_dRS @jeanchristophebelislepipon @varditravitsky @mariapowell @yaelbensoussan @reneeenglish @mariefrancoisemalo #VoiceAI #HealthTech #EthicsInAI #Innovation #Bridge2AI
-
Uživatel Brain Diseases Analysis Laboratory to přesdílel
🌟 Exciting News from the Bridge2AI-Voice Consortium! 🌟 We are thrilled to announce the publication of our latest paper detailing our innovative protocols for data acquisition across multiple disease cohorts encompassing voice, respiratory, neurodegenerative diseases, and mood and anxiety disorders. Our comprehensive approach includes demographic surveys, confounder assessments, acoustic tasks, validated patient-reported outcome (PRO) questionnaires, and clinician-validated diagnostic questions, all designed to enhance the research community's capacity for broader adoption and valuable feedback. This collaborative effort brings together the expertise of numerous dedicated professionals and the Bridge2AI-Voice program, part of Bridge2AI, funded by the NIH Common Fund. As we harness the power of artificial intelligence (AI) to analyze voice, speech, and respiratory sound data, our project aims to create a diverse, ethically sourced voice database linked to health information, propelling Voice AI research into new frontiers. 🎤✨ Continue to follow us to learn more about our work, and to stay up to date on upcoming events from our consortium including data releases and our Voice AI Symposium. 🔗 doi: 10.21437/Interspeech.2024-1926 #Bridge2AI #VoiceAI #Audiomics #TeamScience #HealthcareInnovation #DEI #Bioethics #ClinicalResearch
-
Uživatel Brain Diseases Analysis Laboratory to přesdílel
Exciting advancements in voice data collection! As part of our ongoing efforts to enhance voice AI research, our latest study investigates how easily accessible iOS and Android tablets—both with and without low-cost headset microphones—can deliver recordings on par with traditional research-quality equipment. 🔍 Key findings reveal that recordings made with tablets and headset microphones positioned close to the mouth yielded highly accurate voice measurements, closely correlating with standard research methods. In contrast, using built-in tablet microphones at standard reading distances led to significant variability and less reliable data. 📊 These insights align with the Bridge2AI-Voice Consortium’s recommendations, highlighting the effectiveness of smartphones and headset microphones for large-scale voice data collection across clinical and nonclinical environments. This study opens new doors for practical, high-quality voice data collection, making it easier to fuel innovation in voice AI! 💡🎤 @shaheenawan @ruthbahr @stephaniewatts @micahboyer @robertbudinsky @yaelbensoussan #VoiceAI #DataCollection #ResearchInnovation #VoiceTechnology #Bridge2AI
-
Uživatel Brain Diseases Analysis Laboratory to přesdílel
Overfitting at its finest. Overfitting refers to a machine learning model that is too closely tailored to a particular dataset, leading to poor generalization on new data. A model that overfits is excellent at learning the details and noise of the training data but struggles to perform well on unseen data. 𝗪𝗵𝘆 𝗢𝘃𝗲𝗿𝗳𝗶𝘁𝘁𝗶𝗻𝗴 𝗛𝗮𝗽𝗽𝗲𝗻𝘀: 1. Complex Models: Overly complex algorithms can lead to overfitting by memorizing rather than learning patterns 2. Insufficient Data: A small training dataset can cause model to latch onto noise or minor patterns in the data. 3. Lack of Regularization: Without constraints, models can become too flexible and overfit the training data. 𝗣𝗿𝗲𝘃𝗲𝗻𝘁𝗶𝗻𝗴 𝗢𝘃𝗲𝗿𝗳𝗶𝘁𝘁𝗶𝗻𝗴: 1. Simplify the Model: Use a simpler model architecture that generalizes better. 2. More Data: Train the model on a larger dataset to ensure it learns robust patterns. 3. Cross-Validation: Validate the model on unseen data to ensure it performs well in general. Like this over-specialized doghouse, we must ensure our models don’t just fit perfectly to the training set but generalize well to new data. click "Follow" for more interesting insights and resources on AI/ML & Data Science: Arpit Singh • • #machinelearning #datascience #deeplearning #ai #ml
-
Uživatel Brain Diseases Analysis Laboratory to přesdílel
[English and Spanish below] 🇸🇰 SVK: ESLA Kongres (Európsky kongres logopédie a rečovej terapie) je jeden z top eventov, ktorý sa venuje poruchám reči a ich terapii. Tento rok sa koná v Belgicku a Scicake na ňom aktívne participuje. Spolu s našou poradkyňou na klinickú logopédiu, Neus Calaf, PhD, SLP, mám tú česť prezentovať výsledky nášho prieskumu v Španielsku. Zisťovali sme, ako sa v Španielsku diagnostikuje dysartria a dozvedeli sme sa zásadné informácie. Sledujte Scicake a dozviete sa viac! 🇬🇧 ENG: The ESLA Congress (European Congress of Speech and Language Therapy) is one of the top events addressing speech disorders and their therapy. This year, it is being held in Belgium, and Scicake is actively participating. Along with our Speech-Language Pathology Advisor, Neus Calaf, PhD, SLP, I have the honor of presenting the results of our survey in Spain. We explored the current state of dysarthria assessment in Spain and uncovered essential information. Follow Scicake to learn more! 🇪🇸 ES: El Congreso de ESLA (Congreso Europeo de Logopedia y Terapia del Lenguaje) es uno de los eventos más importantes sobre los trastornos del habla y su terapia. Este año se celebra en Bélgica, y Scicake participa activamente. Junto con nuestra asesora en logopedia clínica, Neus Calaf, PhD, SLP, tengo el honor de presentar los resultados de nuestra encuesta en España. Investigamos cómo se evalúa la disartria en España y descubrimos información clave. ¡Sigue a Scicake para saber más! #Scicake #ESLA2024 #SpeechDisorders #SpeechAndLanguageTherapy #dysarthria #disartria #dysartria #AI